Etanercept-Associated ANCA Vasculitis Presenting as Pauci-Immune Glomerulonephritis and Severe AKI (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0445; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "The patient was treated with intravenous methylprednisolone 500 mg daily for 3 days, followed by prednisone 80 mg daily...She was discharged with nephrology follow-up, and rituximab was planned for outpatient induction...While withdrawal alone may lead to improvement, severe cases often require corticosteroids and additional therapy. Temporal association, exclusion of active disease, and recovery after withdrawal support a drug-induced etiology."
ANCA Vasculitis • Anorexia • Chronic Kidney Disease • Cognitive Disorders • Glomerulonephritis • Hematological Disorders • Hepatitis B • Hepatitis C • Hepatology • Human Immunodeficiency Virus • Immunology • Infectious Disease • Inflammatory Arthritis • Lupus Nephritis • Nephrology • Psoriasis • Renal Disease • Rheumatoid Arthritis • Vasculitis
|
|
Yoan Ernesto Rodriguez; Bhaktidevi Makadia; Shiguang Liu; Sukriti Seth
|